Novo Nordisk
NVO
#110
Rank
C$258.01 B
Marketcap
C$58.53
Share price
0.96%
Change (1 day)
-15.10%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): C$3.85

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is C$5.62. In 2022 the company made an earnings per share (EPS) of C$3.09 an increase over its 2021 EPS that were of C$2.84.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$3.8524.63%
2022C$3.099.01%
2021C$2.8415.08%
2020C$2.4614.83%
2019C$2.15-1.68%
2018C$2.184.96%
2017C$2.0831.08%
2016C$1.59-10.33%
2015C$1.7713.91%
2014C$1.554.03%
2013C$1.49-28.81%
2012C$2.10108.9%
2011C$1.0025.59%
2010C$0.8035.01%
2009C$0.59-9.17%
2008C$0.6561.35%
2007C$0.4028.96%
2006C$0.3125.63%
2005C$0.254.17%
2004C$0.2413.55%
2003C$0.2136.87%
2002C$0.15-6.99%
2001C$0.1721.56%
2000C$0.1449.45%
1999C$0.091163.78%
1998C$0.0878412.15%
1997C$0.0783224.74%
1996C$0.06278

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.01-82.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.00 682.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.82-49.81%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$6.44 14.55%๐Ÿ‡บ๐Ÿ‡ธ USA